+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cancer Targeted Therapy"

From
From
Cancer Supportive Care Drugs Global Market Report 2024 - Product Thumbnail Image

Cancer Supportive Care Drugs Global Market Report 2024

  • Report
  • July 2024
  • 175 Pages
  • Global
From
From
Particle Therapy Market Report 2025 - Product Thumbnail Image

Particle Therapy Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
Antibody Drug Conjugates Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Antibody Drug Conjugates Market - Forecasts from 2024 to 2029

  • Report
  • February 2024
  • 210 Pages
  • Global
From
FYARRO Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

FYARRO Market Size, Forecast, and Market Insight - 2032

  • Report
  • March 2024
  • 30 Pages
  • Global
From
From
Cancer Therapeutics Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cancer Therapeutics Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
Targeted Oncology Therapeutics: Hematology Cancers - Product Thumbnail Image

Targeted Oncology Therapeutics: Hematology Cancers

  • Report
  • October 2021
  • 110 Pages
  • Global
From
Drug Delivery in Cancer - Technologies, Markets & Companies - Product Thumbnail Image

Drug Delivery in Cancer - Technologies, Markets & Companies

  • Report
  • November 2021
  • 747 Pages
  • Global
From
Loading Indicator

Cancer Targeted Therapy is a type of oncology drug that specifically targets cancer cells, leaving healthy cells unharmed. These drugs are designed to block the growth and spread of cancer cells, and can be used in combination with other treatments such as chemotherapy and radiation. Cancer Targeted Therapy drugs can be divided into two categories: small molecule drugs and monoclonal antibodies. Small molecule drugs are designed to target specific proteins or enzymes that are involved in the growth and spread of cancer cells, while monoclonal antibodies are designed to target specific molecules on the surface of cancer cells. The Cancer Targeted Therapy market is an important part of the oncology drug market, as it offers a more targeted approach to treating cancer. This type of therapy is becoming increasingly popular due to its ability to reduce side effects and improve patient outcomes. Some companies in the Cancer Targeted Therapy market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more